Safety and tolerance of trimetrexate: results of a phase II multicenter study in patients with metastatic cancer refractory to conventional therapy or for which no conventional therapy exists
Stewart, J.A.
Seminars in Oncology 15(2 Suppl. 2): 10-16
1988
ISSN/ISBN: 0093-7754 PMID: 2966981 Document Number: 322917
Document emailed within 1 workday
Related Documents
Sciascia, S.; Giachino, O.; Roccatello, D. 2012: Prevention of thrombosis relapse in antiphospholipid syndrome patients refractory to conventional therapy using intravenous immunoglobulin Clinical and Experimental Rheumatology 30(3): 409-413Marotta, G.; Bigazzi, C.; Lenoci, M.; Tozzi, M.; Bocchia, M.; Lauria, F. 2000: Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapy Haematologica 85(12): 1268-1270
Hudes, G.R.; Comis, R.L. 1988: Phase 1 and 2 studies of trimetrexate administered in combination with fluorouracil to patients with metastatic cancer Seminars in Oncology 15(2 Suppl 2: 41-45
Knönagel, H.; Bolle, J.F.; Hering, F.; Senn, E.; Hodel, T.; Neuenschwander, H.; Biedermann, C. 1989: Therapy of metastatic prostatic cancer by orchiectomy plus Anandron versus orchiectomy plus placebo. Initial results of a randomized multicenter study Helvetica Chirurgica Acta 56(3): 343-345
Fornaro, G.; Lazzero, M.; Giacalone, A.; Aralda, D.; Prando, M.Domenica.; Rossi, L.; Bongo, A.Sante. 2008: Death after ST-elevation myocardial infarction in patients treated with fibrinolytic therapy, angioplasty, or conventional therapy. A post-mortem study to verify cardiac rupture as a cause of death Giornale Italiano di Cardiologia 9(6): 408-420
Muthalib, A.; Darwis, I.; Prayogo, N.; Sutjipto 2000: Preliminary results of multicenter phase Ii trial of docetaxel (Taxotere) in combination with doxorubicin as first line chemotherapy in Indonesian patients with advanced or metastatic breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 498-504
Nitschke, R.; Starling, K.; Lui, V.K.; Pullen, J. 1981: Doxorubicin and cisplatin therapy in children with neuroblastoma resistant to conventional therapy: a Southwest Oncology Group Study Cancer Treatment Reports 65(11-12): 1105-1108
Wei, J.Y.; Bulkley, B.H.; Schaeffer, A.H.; Greene, H.L.; Reid, P.R. 1978: Mitral-valve prolapse syndrome and recurrent ventricular tachyarrhythmias: a malignant variant refractory to conventional drug therapy Annals of Internal Medicine 89(1): 6-9
Tanaka, K.; Kaetsu, T.; Suzuki, S.; Kusano, M.; Yajima, S.; Sakamaki, H.; Ikeda, S.; Ikegami, N.; Murayama, J-Ichiro. 2003: Pharmacoeconomic study of chemotherapy for gastric cancer: analysis of medical costs for oral fluoropyrimidine TS-1 and conventional i.v therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(1): 73-80
Morganti, A.; Piffanelli, A.; Mantero, F. 1993: Results of the Italian Multicenter Study for Standardization of Renin Measurement with immunoradiometric assay: comparison with the conventional enzymatic method Journal of hypertension. Supplement: official journal of the International Society of Hypertension 11(5): S228-S229
Federico, M.; Clò, V.; Carella, A.M. 1996: High-dose therapy autologous stem cell transplantation vs conventional therapy for patients with advanced Hodgkin's disease responding to first-line therapy: analysis of clinical characteristics of 51 patients enrolled in the HD01 protocol. EBMT/ANZLG/Intergroup HD01 Trial Leukemia 10 Suppl. 2: S69-S71
Arntz, H.R.; Wunderlich, W.; Schnitzer, L.; Stern, R.; Fischer, F.; Agrawal, R.; Linderer, T.; Schultheiss, H.P. 1999: Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study Zeitschrift für Kardiologie 88(8): 582-590
Gao, Q-Neng. 2019: Stereotactic body radiation therapy versus conventional intensity-modulated radiation therapy for the treatment of prostate cancer Zhonghua Nan Ke Xue 25(5): 424-429
Meigel, W.; Mack-Hennes, A. 1988: Acne therapy with isotretinoin in dermatologic practice. a multicenter phase IV study of 788 patients Zeitschrift für Hautkrankheiten 63(1): 15-22
Creech, R.H.; Catalano, R.B.; Dierks, K.M.; Shah, M.K. 1984: Phase Ii study of mitolactol in chemotherapy-refractory metastatic breast cancer Cancer Treatment Reports 68(12): 1499-1501
Pfeiffer, T.; Reiher, L.; Grabitz, K.; Sandmann, W. 2000: Results of conventional surgical therapy of abdominal aortic aneurysms since the beginning of the "endovascular era" Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 71(1): 72-79
Malý, Z. 1994: Comparison of the results of conventional ultrasonography and color doppler analysis in the evaluation of the nature of adnexal tumors. I. Conventional vaginal ultrasound Ceska Gynekologie 59(5): 250-258
Lück, H.J.; Thomssen, C.; du Bois, A.; Lisboa, B.W.; Untch, M.; Kühnle, H.; Jänicke, F.; Meerpohl, H.G.; Lindner, C.; Konecny, G.; Hecker, D.; Diergarten, K. 1997: Preliminary results of a phase Ii study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer Seminars in Oncology 24(1 Suppl 3: S13-S16
Weissbach, L. 1992: Prospective randomized multicenter phase IIi study of treatment of hormone refractory prostatic cancer: mitomycin C vs. 4-epirubicin vs. estramustine phosphate Der Urologe. Ausg. a 31(1): 62
Malesker, M.A.; Hilleman, D.E. 2010: Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapy Managed Care 19(7): 36-42